Assistant Professor, Medicine, UCSD School of Medicine

Internal Medicine

Dr. Matthew J. Wieduwilt, MD


Matthew Wieduwilt practices Internal Medicine. He went to University of Texas Southwestern Medical School. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Matthew Wieduwilt is a published MD as well. He has 6 publications published. The latest was: Immunochemotherapy with Intensive Consolidation for Primary Central Nervous System Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI. Doctor Matthew J. Wieduwilt, MD accepts Medicare payments and is listed with Medicare.gov.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Drug Facts


NPI NUMBER   1124227483
NPPES Provider LastName   WIEDUWILT
NPPES Provider FirstName   MATTHEW
NPPES Provider ZIPCode   920931503
NPPES Provider State   CA
Specialty Description   Hematology/Oncology
Total Claim Count   247.0
Distinct Opioid Count   0.0
Opioid Claim Count   0.0
Percent Opioid Claims   0.0

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1124227483
Last Name Of The Provider WIEDUWILT
First Name Of The Provider MATTHEW
View All

Similar Doctors


Dr. Sally Kim, MD
This Doctor is OpenDoctor Recommended.
Dr. Heidi L. Fagerlund, DO
Dr. Srikanth I. Seethala, MD
This Doctor is OpenDoctor Recommended.
Dr. Michael F. Maywood, MD
This Doctor is OpenDoctor Recommended.
Dr. Khamisah Barger, MD
This Doctor is OpenDoctor Recommended.
Dr. Joel I. Bernstein, MD
This Doctor is OpenDoctor Recommended.
Dr. James M. Sinclair, MD
This Doctor is OpenDoctor Recommended.
Dr. Gregory A. Daniels, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Robert P. Brouillard, MD
Dr. Huan-You Wang, MD
Dr. Kevin T. Kim, MD
Dr. Eric J. Roeland, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Caron E. Steinmetz, MD
Dr. Sonia L. Ali, MD
Dr. Michael Graves, MD


Doctor Directory | TOS | twitter | FB | Angel | blog